Energy and Resources Group, University of California, Berkeley (UC Berkeley), Berkeley, California, USA.
Division of Epidemiology and Biostatistics, UC Berkeley, Berkeley, California, USA.
Environ Health Perspect. 2023 Jan;131(1):16001. doi: 10.1289/EHP10839. Epub 2023 Jan 30.
Centralized chlorination of urban piped water supplies has historically contributed to major reductions in waterborne illness. In locations without effective centralized water treatment, point-of-use (POU) chlorination for households is widely promoted to improve drinking water quality and health. Realizing these health benefits requires correct, consistent, and sustained product use, but real-world evaluations have often observed low levels of use. To our knowledge, no prior reviews exist on adoption of chlorine POU products.
Our objectives were to identify which indicators of adoption are most often used in chlorine POU studies, summarize levels of adoption observed, understand how adoption changes over time, and determine how adoption is affected by frequency of contact between participants and study staff.
We conducted a systematic review of household POU chlorination interventions or programs from 1990 through 2021 that reported a quantitative measure of adoption, were conducted in low- and middle-income countries, included data collection at households, and reported the intervention start date.
We identified 36 studies of household drinking water chlorination products that met prespecified eligibility criteria and extracted data from 46 chlorine intervention groups with a variety of chlorine POU products and locations. There was no consensus definition of adoption of household water treatment; the most common indicator was the proportion of household stored water samples with free chlorine residual . Among studies that reported either free or total chlorine-confirmed adoption of chlorine POU products, use was highly variable (across all chlorine intervention groups at the last time point measured in each study; range: 1.5%-100%; sample size-weighted ; unweighted ). The median follow-up duration among intervention groups was 3 months. On average, adoption declined over time and was positively associated with frequency of contact between respondents and study staff.
Although prior research has shown that POU chlorine products improve health when correctly and consistently used, a reliance on individual adoption for effective treatment is unlikely to lead to the widespread public health benefits historically associated with pressurized, centralized treatment of piped water supplies. https://doi.org/10.1289/EHP10839.
集中氯化城市供水管网在历史上为减少水传播疾病做出了重大贡献。在没有有效集中水处理的地方,广泛推广家庭使用点(POU)氯化来改善饮用水质量和健康。要实现这些健康益处,需要正确、一致和持续地使用产品,但实际评估往往观察到使用率较低。据我们所知,以前没有关于 POU 氯产品采用的评论。
我们的目标是确定 POU 氯产品采用最常用的指标,总结观察到的采用水平,了解采用情况随时间的变化,并确定参与者与研究人员之间的接触频率如何影响采用。
我们对 1990 年至 2021 年间发表的定量衡量采用情况的家庭 POU 氯化干预或方案进行了系统回顾,这些方案在低收入和中等收入国家进行,包括在家庭中进行的数据收集,并报告了干预开始日期。
我们确定了 36 项符合预定资格标准的家庭饮用水氯化产品研究,并从 46 个具有各种 POU 氯产品和位置的家用饮用水氯化干预组中提取数据。家庭水处理采用的定义没有共识;最常用的指标是家庭储存水样中游离氯残留的比例。在报告家用水 POU 产品游离或总氯确认采用的研究中,使用率差异很大(在每个研究的最后一次测量点上,所有氯干预组;范围:1.5%-100%;样本量加权;未加权)。干预组的中位随访时间为 3 个月。平均而言,采用率随时间下降,并与受访者与研究人员之间的接触频率呈正相关。
尽管先前的研究表明,POU 氯产品在正确和一致使用时可以改善健康,但依靠个人采用来进行有效的治疗不太可能导致历史上与加压、集中处理供水管网相关的广泛公共卫生效益。https://doi.org/10.1289/EHP10839.